Abstract
Renal cell carcinoma has one of the highest mortality rates of genitourinary cancers (Cairns, Cancer Biomark 9:461–473, 2012). The incidence of this disease has risen steadily. However, survival rates have improved substantially due to an increase in incidental detection and active surveillance with early treatment and management. Despite the control of cancer progression and better survival, patients are still being diagnosed with advanced disease and metastases. A collaborative management strategy consisting of surgery and targeted therapy is needed to improve patient outcomes (Cairns, Cancer Biomark 9:461–473, 2012).
References
American Cancer Society (ACS). Kidney cancer stages. 2017. Retrieved from www.amp.cancer.org/cncer/kidney-cancer/detection-diagnosis-staging
American Cancer Society. Key statistics about kidney cancer. 2019. Retrieved from https://www.cancer.org/cancer/kidney-cancer/about/key-statistics.html
Chapman D, Moore R, Klarenbach S, Braam B. Residual renal function after partial or radical nephrectomy for renal cell carcinoma. Can Urol Assoc J = J Assoc Urol Can. 2010;4(5):337–43.
Centers for Disease Control and Prevention. Kidney cancer. 2018. Retrieved from https://www.cdc.gov/cancer/kidney/index.htm
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods, and major patterns in globcan 2012. Int J Cancer. 2015;136(5):E359–86. Retrieved from http://onlinelibrary.wiley.com/doi/10.1002/ijc.29210/full
Hass NB, Nathanson KL. Hereditary renal cancer syndromes. Adv Chronic Kidney Dis. 2015;21(1). Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872053/
Kabaria R, Klaassen Z, Terris MK. Renal cell carcinoma: links and risks. Int J Nephrol Renov Dis. 2016;9:45–52. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790506/
Kang SK, Chandarana H. Contemporary imaging of the renal mass. Urol Clin N Am. 2012;39(2):161–70.
Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer. 2011;11:886–95. Retrieved from https://www.nature.com/articles/nrc3174
Liao LM, Schwartz K, Pollack M, et al. Serum leptin and adiponectin levels and risk for renal cell carcinoma. Obesity. 2013;21(7):1478–85. Retrieved from http://onlinelibrary.wiley.com/doi/10.1002/ijc.29210/full
Mandani A, Patidar N, Pallavi A, Pande S, Tewari P. A new classification of inferior vena cava thrombus in renal cell carcinoma could define the need for cardiopulmonary or venovenous bypass. Indian J Urol. 2015;31(4):327–32.
Nabi S, Kessler ER, Bernard D, et al. Renal cell carcinoma: a review of biology and pathophysiology. F1000 Res. 2018. Retrieved from https://f1000researchdata.s3.amazonaws.com/manuscripts/14298/1fe5f611-34dd-4484-a862-97cc95be024b_13179_-_Thomas_Flaig.pdf?doi=10.12688/f1000research.13179.1
National Cancer Institute. Cancer stat facts: kidney and renal pelvis cancer. 2018. Retrieved from https://seer.cancer.gov/statfacts/html/kidrp.html
Palsodttir H, Hardarson S, Petursdottir V, Jonsson A, Jonsson E, Sigurdsson I, Einarsson E, Gudbjartsson T. Incidental detection of renal cell carcinoma as in independent prognostic marker. J Urol. 2012;187(1):48–53.
Parker A, Lohse C, Leibovich B, Igel T, Blute M. Evaluation of the association of current cigarette smoking and outcome for patients with clear cell renal cell carcinoma. Int J Urol. 2008;15(4):304–8.
Reuter S, Gupta SC, Chaturvedi MM, et al. Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med. 2010;49(11):1603–16. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990475/
Rink M, Xylinas E, Margulis V, et al. Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. Eur Urol. 2013;63(6):1082–90. Retrieved from http://www.europeanurology.com/article/S0302-2838(12)00730-0/fulltext
Sanfilippo KM, McTigue KM, Fidler CJ, et al. Hypertension and obesity and the risk of kidney cancer in two large cohorts of US men and women. Hypertension. 2014;63(5):934–41. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098147/
The National Comprehensive Cancer Network for patients with kidney cancer. 2017. Retrieved from www.nccn.org/patients/guidelines/kidney
Tsivian M, Moreira DM, Caso JR, et al. Cigarette smoking is associated with advanced renal cell carcinoma. J Clin Oncol. 2011. Retrieved from http://ascopubs.org/doi/full/10.1200/JCO.2010.30.9484
US Department of Health and Human Services. The health consequences of smoking- 50 years of progress. 2014. Retrieved from http://www.surgeongeneral.gov/library/reports/50-years-of-progress/full-report.pdf
Zhang ZL, Li HY, Zhou JF. Complications of radical nephrectomy for renal cell carcinoma. 2015. Retrieved from https://www.ncbi.nlm.nih.gov
Cairns P. Renal cell carcinoma. Cancer Biomark. 2012;9(1–6):461–73.
Zhang Z-L, Li Y-H, Luo J-H, Liu Z-W, Yao K, Dong P, Han H, Qin Z-K, Chen W, Zhou F-J. Complications of radical nephrectomy for renal cell carcinoma: a retrospective study comparing transperitoneal and retroperitoneal approaches using a standardized reporting methodology in two Chinese centers. Chin J Cancer. 2013;32(8):461–8.
AlBalawi Z, Gramlich L, Nelson G, Senior P, Youngson E, McAlister FA. The impact of the implementation of the enhanced recovery after surgery (ERAS®) program in an entire health system: a natural experiment in Alberta, Canada. World J Surg. 2018;42(9):2691–700.
Martin TD, Lorenz T, Ferraro J, Chagin K, Lampman RM, Emery KL, Zurkan JE, Boyd JL, Montgomery K, Lang RE, Vandewarker JF, Cleary RK. Newly implemented enhanced recovery pathway positively impacts hospital length of stay. Surg Endosc. 2016;30(9):4019–28.
Martin LW, Sarosiek BM, Harrison MA, Hedrick T, Isbell JM, Krupnick AS, Lau CL, Mehaffey JH, Thiele RH, Walters DM, Blank RS. Implementing a thoracic enhanced recovery program: lessons learned in the first year. Ann Thorac Surg. 2018;105(6):1597–604.
Smith HJ, Boitano TKL, Rushton T, Johnston MC, Leath CA, Straughn JM. Impact of enhanced recovery after surgery (ERAS) protocol on postoperative pain control in chronic narcotic users. Gynecol Oncol. 2018;149:19.
Thiele RH, Raghunathan K, Brudney CS, Lobo DN, Martin D, Senagore A, Cannesson M, Gan TJ, Mythen MMG, Shaw AD, Miller TE, For the Perioperative Quality Initiative (POQI) I Workgroup. American Society for Enhanced Recovery (ASER) and Perioperative Quality Initiative (POQI) joint consensus statement on perioperative fluid management within an enhanced recovery pathway for colorectal surgery. Perioper Med. 2016;5(1):1–15.
Thiele RH, Rea KM, Turrentine FE, Friel CM, Hassinger TE, Goudreau BJ, Umapathi BA, Kron IL, Sawyer RG, Hedrick TL, McMurry TL. Standardization of care: impact of an enhanced recovery protocol on length of stay, complications, and direct costs after colorectal surgery. J Am Coll Surg. 2015;220(4):430–43.
American Society of Anesthesiologists. Maintaining blood pressure levels measured before entering O.R. may improve outcomes. 2015. Retrieved from www.asahg.org/about-asa/newsroom/news-releases/2015/10/maintaining-blood-pressure-levels
Chapman E, Pichel A. Anesthesia for nephrectomy. BJA Educ. 2015;16(3):98–101.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Stapleton, C., Duffy, C., Duplisea, J. (2019). Perioperative Management of the Genitourinary Oncologic Patient Undergoing Partial/Radical Nephrectomy. In: Nates, J., Price, K. (eds) Oncologic Critical Care. Springer, Cham. https://doi.org/10.1007/978-3-319-74698-2_181-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-74698-2_181-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74698-2
Online ISBN: 978-3-319-74698-2
eBook Packages: Springer Reference MedicineReference Module Medicine